Pharmaceutical Intermediates

« All Products

Pharmaceutical Intermediates

Pharmaceutical Intermediates · 64 products

Key intermediates for API synthesis across cardiovascular, metabolic, oncology, anti-infective and immunology programmes, plus general heterocyclic building blocks — supplied through audited partner plants. COA and MSDS available on request. The range also covers GI & respiratory intermediates and protected amino acids, PEG linkers and fatty-chain modifiers for peptide and GLP-1 API programmes.

StructureCAS No.Product NameSub-categoryAssay
2-Butyl-5-chloro-1H-imidazole-4-carbaldehyde structure83857-96-92-Butyl-5-chloro-1H-imidazole-4-carbaldehydeCardiovascular99%
2-Cyano-4'-methylbiphenyl structure114772-53-12-Cyano-4′-methylbiphenylCardiovascular99%
4'-(Bromomethyl)-2-cyanobiphenyl structure114772-54-24′-(Bromomethyl)-2-cyanobiphenylCardiovascular99%
5-[4'-(Bromomethyl)biphenyl-2-yl]-1-trityl-1H-tetrazole structure124750-51-25-[4′-(Bromomethyl)biphenyl-2-yl]-1-trityl-1H-tetrazoleCardiovascular99%
tert-Butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate structure124655-09-0tert-Butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetateCardiovascular99%
(2S)-2-[(tert-Butoxycarbonyl)amino]-2-(3-hydroxyadamantan-1-yl)acetic acid structure361442-00-4(2S)-2-[(tert-Butoxycarbonyl)amino]-2-(3-hydroxyadamantan-1-yl)acetic acidAnti-diabetic99%
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride structure762240-92-63-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochlorideAnti-diabetic99%
Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid structure486460-00-8Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acidAnti-diabetic99%
Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-alpha-D-xylo-hexopyranoside structure1528636-39-6Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-alpha-D-xylo-hexopyranosideAnti-diabetic99%
Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-alpha-D-glucopyranoside structure1279691-36-9Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-alpha-D-glucopyranosideAnti-diabetic99%
(E)-6-Nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole structure886230-75-7(E)-6-Nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazoleAnti-cancer99%
2,3-Dimethyl-2H-indazol-6-amine structure444731-72-02,3-Dimethyl-2H-indazol-6-amineAnti-cancer99%
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine structure330786-24-83-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amineAnti-cancer99%
4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine structure941685-27-44-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidineAnti-cancer99%
4-(4-Amino-3-chlorophenoxy)-N-methylpicolinamide structure284462-44-84-(4-Amino-3-chlorophenoxy)-N-methylpicolinamideAnti-cancer99%
4-[(6,7-Dimethoxyquinolin-4-yl)oxy]aniline structure190728-25-74-[(6,7-Dimethoxyquinolin-4-yl)oxy]anilineAnti-cancer99%
4-Chloro-6,7-dimethoxyquinoline structure35654-56-94-Chloro-6,7-dimethoxyquinolineAnti-cancer99%
4-Chloro-7-methoxyquinoline-6-carboxamide structure417721-36-94-Chloro-7-methoxyquinoline-6-carboxamideAnti-cancer99%
4-Phenoxyphenylboronic acid structure51067-38-04-Phenoxyphenylboronic acidAnti-cancer99%
5-Bromo-1-[2-Fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione structure830346-48-05-Bromo-1-[2-Fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dioneAnti-cancer99%
5-Bromo-1H-pyrrolo[2,3-b]pyridine structure183208-35-75-Bromo-1H-pyrrolo[2,3-b]pyridineAnti-cancer99%
6-Iodo-1H-indazole structure261953-36-06-Iodo-1H-indazoleAnti-cancer99%
9-Bromo-6,11-dihydro-8-hydroxy-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile structure1256579-06-29-Bromo-6,11-dihydro-8-hydroxy-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrileAnti-cancer99%
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine structure152460-09-8N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amineAnti-cancer99%
N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine structure162012-67-1N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamineAnti-cancer99%
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine structure179552-74-0N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amineAnti-cancer99%
(2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine structure863329-66-2(2’R)-2′-Deoxy-2′-fluoro-2′-methyluridineAnti-infective & antiviral99%
(2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide structure1192651-49-2(2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamideAnti-infective & antiviral99%
(R)-9-(2-Hydroxypropyl)adenine structure14047-28-0(R)-9-(2-Hydroxypropyl)adenineAnti-infective & antiviral99%
2-Amino-6-chloropurine structure10310-21-12-Amino-6-chloropurineAnti-infective & antiviral99%
6-Aminopenicillanic acid structure551-16-66-Aminopenicillanic acidAnti-infective & antiviral99%
7-Aminocephalosporanic acid structure957-68-67-Aminocephalosporanic acidAnti-infective & antiviral99%
2-(Chloromethyl)-3,4-dimethoxypyridine hydrochloride structure72830-09-22-(Chloromethyl)-3,4-dimethoxypyridine hydrochlorideGI & respiratory99%
2-(Chloromethyl)-3,5-dimethyl-4-methoxypyridine hydrochloride structure86604-75-32-(Chloromethyl)-3,5-dimethyl-4-methoxypyridine hydrochlorideGI & respiratory99%
5-Methoxy-2-mercaptobenzimidazole structure37052-78-15-Methoxy-2-mercaptobenzimidazoleGI & respiratory99%
7-Chloro-2-methylquinoline structure4965-33-77-Chloro-2-methylquinolineGI & respiratory99%
N-Methyl-1-(methylthio)-2-nitroethenamine structure61832-41-5N-Methyl-1-(methylthio)-2-nitroethenamineGI & respiratory98%
(R)-4-Propyl-dihydro-furan-2-one structure63095-51-2(R)-4-Propyl-dihydro-furan-2-oneNeuro & analgesic99%
2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one structure277299-70-42-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-oneNeuro & analgesic99%
4-(Piperidin-4-yl)morpholine structure53617-35-94-(Piperidin-4-yl)morpholineNeuro & analgesic99%
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine structure477600-70-7(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amineImmunology & anti-inflammatory99%
1-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole structure1003846-21-61-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazoleImmunology & anti-inflammatory99%
3-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile structure1153949-38-23-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrileImmunology & anti-inflammatory99%
N-(4-Aminobenzoyl)-L-glutamic acid structure4271-30-1N-(4-Aminobenzoyl)-L-glutamic acidImmunology & anti-inflammatory99%
18-(tert-Butoxy)-18-oxooctadecanoic acid structure843666-40-018-(tert-Butoxy)-18-oxooctadecanoic acidPeptides & linkers97%
Fmoc-AEEA-OH structure166108-71-0Fmoc-AEEA-OHPeptides & linkers98%
Fmoc-D-tryptophan structure86123-11-7Fmoc-D-tryptophanPeptides & linkers98%
L-Pyroglutamic acid structure98-79-3L-Pyroglutamic acidPeptides & linkers99%
(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate structure1420478-88-1(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylateBuilding blocks & others99%
1-Chloro-2-[(4-ethoxyphenyl)methyl]-4-iodobenzene structure1103738-29-91-Chloro-2-[(4-ethoxyphenyl)methyl]-4-iodobenzeneBuilding blocks & others99%
2-Aminomethylpyrimidine Monohydrochloride structure372118-67-72-Aminomethylpyrimidine MonohydrochlorideBuilding blocks & others99%
2-Methoxy-5-[[[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]benzoic acid methyl ester structure1391712-57-42-Methoxy-5-[[[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]benzoic acid methyl esterBuilding blocks & others99%
3'-Amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid structure376592-93-73′-Amino-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acidBuilding blocks & others99%
4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carbonitrile structure924898-13-54-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carbonitrileBuilding blocks & others99%
4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine structure623950-02-74-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanineBuilding blocks & others99%
4-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrile structure906673-45-84-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrileBuilding blocks & others99%
4-[4-Bromo-3-[(methoxymethoxy)methyl]phenoxy]benzonitrile structure947162-14-34-[4-Bromo-3-[(methoxymethoxy)methyl]phenoxy]benzonitrileBuilding blocks & others99%
4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxy methyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid ethylester structure330785-83-64-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxy methyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid ethylesterBuilding blocks & others99%
4-Hydroxypyridine structure626-64-24-HydroxypyridineBuilding blocks & others99%
7-Chloro-4-methyl-4,5-dihydro-3H-benzo[e][1,4]diazepin-2-amine structure1784753-97-47-Chloro-4-methyl-4,5-dihydro-3H-benzo[e][1,4]diazepin-2-amineBuilding blocks & others99%
N,N-Dimethylethylenediamine structure108-00-9N,N-DimethylethylenediamineBuilding blocks & others99%
N-(2-Chloro-4-hydroxyphenyl)-N'-cyclopropyl-urea structure796848-79-8N-(2-Chloro-4-hydroxyphenyl)-N’-cyclopropyl-ureaBuilding blocks & others99%
tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate structure877399-74-1tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylateBuilding blocks & others99%
trans-4-[(Pyridin-2-yl)oxy]cyclohexanecarboxylic hydrazide structure1228087-48-6trans-4-[(Pyridin-2-yl)oxy]cyclohexanecarboxylic hydrazideBuilding blocks & others99%
Quality & documentation — batch-specific COA with HPLC purity and impurity profile; chiral purity by chiral HPLC where stereocentres are defined; residual solvent and elemental impurity data against ICH Q3C/Q3D on request; structure confirmation by NMR and MS on first shipments; SDS in the language of your market with GHS classification.

Looking for an intermediate that is not listed? We source the wider Chinese fine-chemical range on request — send the CAS number or structure and we will confirm availability, documentation and lead time.

Send your request

Need COA, MSDS or a quote?

Email info@laurandchem.com or call +86-21-6718 6289 (office) — we reply within one business day.

Get a Quote